Skip to content

Comprehension of Research Informed Consent When Applied Through a Telemedicine Medium

Comprehension of Research Informed Consent When Applied Through a Telemedicine Medium

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02541799
Enrollment
130
Registered
2015-09-04
Start date
2015-06-30
Completion date
2015-09-30
Last updated
2015-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Informed Consent

Keywords

informed consent, telemedicine, research methods

Brief summary

The investigators hypothesis is that patient comprehension of telemedicine-enabled research informed consent is not inferior to standard face-to-face research informed consent. The procotol will involve a prospective, randomized control trial to test the effectiveness of a telemedicine medium in obtaining research informed consent. Within a single emergency department, the investigators will conduct a simple, low risk randomized trial (single does of oral chlorhexideine to prevent hospital acquired pneumonia among adult patients with expected hospital admission). Prior to being approached for informed consent, potential participants will be randomized in a 1:1 allocation ratio to standard face-to-face consent vs. consent provided by audio-visual telemedicine. After standard clinical care, potential participants will be approached according to their allocation. Comprehension of research informed consent will be the primary outcome, and will be measured using the modified Quality of Informed Consent (QuIC) instrument.

Interventions

PROCEDUREAudio-visual telemedicine

Participants in an emergency department will have their care delivered using telemedicine, then they will be approached for a study by a study investigator using the same telemedicine link

PROCEDUREStandard care

Participants in an emergency department will have their care delivered in person, then they will be approached by a study investigator face-to-face.

Sponsors

University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* any adult patient presenting to the emergency department, and expected to be admitted to the hospital.

Exclusion criteria

* prisoners * pregnant patients * non-English speaking patients * unable to provide informed consent based on mental status.

Design outcomes

Primary

MeasureTime frameDescription
Comprehension of research informed consentImmediatelyComprehension of research informed consent will be assessed within 30 minutes of approaching participants for study inclusion. The QuIC will be used to assess comprehension of the elements of research informed consent.

Secondary

MeasureTime frameDescription
Consent rateImmediatelyRate of consenting for a low-risk clinical trial in the emergency department, depending on how research participation was solicited.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026